Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

Andrea J. Gonzales, Patrick W. Vincent(Pfizer (United States))
Molecular Cancer Therapeutics
July 1, 2008
Cited by 221


Related Papers

No related papers found

Powered by citation graph analysis